Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.

about

Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity.

P2860

Q53697010-8F6879F2-4CB0-459B-8915-315ACBFA432D

P2860

Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.

Item

http://www.wikidata.org/entity/Q47677671

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Ceftaroline efficacy against h ...... hollow-fibre infection model.

@en

Ceftaroline efficacy against h ...... hollow-fibre infection model.

@nl

type

Item

label

Ceftaroline efficacy against h ...... hollow-fibre infection model.

@en

Ceftaroline efficacy against h ...... hollow-fibre infection model.

@nl

prefLabel

Ceftaroline efficacy against h ...... hollow-fibre infection model.

@en

Ceftaroline efficacy against h ...... hollow-fibre infection model.

@nl

P1476

Ceftaroline efficacy against h ...... hollow-fibre infection model.

@en

P2093

April Chen

http://www.w3.org/2001/XMLSchema#string

Jane E Ambler

http://www.w3.org/2001/XMLSchema#string

Maryann San Martin

http://www.w3.org/2001/XMLSchema#string

Mashal Almutairi

http://www.w3.org/2001/XMLSchema#string

Renu Singh

http://www.w3.org/2001/XMLSchema#string

Richard A Alm

http://www.w3.org/2001/XMLSchema#string

Sushmita D Lahiri

http://www.w3.org/2001/XMLSchema#string

P2860

Ceftaroline fosamil: A super-cephalosporin?

Does the dose matter?

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.

Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid.

Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects

Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus.

Methicillin-resistant Staphylococcus aureus: source control and surveillance organization.

Optimizing dosage to prevent emergence of resistance - lessons from in vitro models.

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.

P304

2796-2803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKX214

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29091195

http://www.w3.org/2001/XMLSchema#string

Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.

about

P2860

P2860

Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698